Andreas Vogt Selected Research

Liver Transplantation

7/2019

Orthotopic Liver Transplant in a Patient Anticoagulated With Rivaroxaban: A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Vogt Research Topics

Disease

20	Neoplasms (Cancer) 01/2019 - 01/2005
7	Breast Neoplasms (Breast Cancer) 10/2018 - 08/2009
4	Pulmonary Atelectasis 01/2023 - 12/2009
2	Infections 01/2023 - 02/2008
2	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2019
2	Inflammation (Inflammations) 01/2016 - 08/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2015 - 05/2013
2	Lung Neoplasms (Lung Cancer) 10/2009 - 08/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2023
1	Heart Failure 01/2023
1	Pulmonary Hypertension 01/2023
1	COVID-19 01/2021
1	Hemolytic Anemia 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Hyperglycemia 01/2020
1	Thrombosis (Thrombus) 07/2019
1	Liver Diseases (Liver Disease) 07/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Venous Thromboembolism 01/2017
1	Hypoxia (Hypoxemia) 08/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Ischemia 01/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Parkinson Disease (Parkinson's Disease) 06/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2013
1	Wounds and Injuries (Trauma) 05/2013
1	Leukemia 05/2013
1	Hypovolemia 03/2013
1	Hypertrophy 08/2012
1	Glioma (Gliomas) 06/2012

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2005
5	Phosphotransferases (Kinase)IBA 01/2019 - 01/2004
4	Mitogen-Activated Protein KinasesIBA 01/2017 - 01/2004
4	Dual-Specificity PhosphatasesIBA 01/2017 - 01/2005
3	Oxygen (Dioxygen)IBA 01/2023 - 06/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2019
3	Insulin (Novolin)FDA Link 01/2021 - 12/2019
3	TubulinIBA 01/2015 - 11/2005
3	Excipients (Suspending Agents)IBA 06/2011 - 07/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2011 - 11/2005
2	Profilins (Profilin)IBA 10/2018 - 01/2014
2	Mitogen-Activated Protein Kinase PhosphatasesIBA 01/2017 - 02/2008
2	dictyostatinIBA 06/2011 - 11/2005
1	Peptides (Polypeptides)IBA 12/2023
1	empagliflozinIBA 01/2023
1	Investigational DrugsIBA 01/2021
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 01/2021
1	FructoseIBA 01/2020
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2020
1	insulin degludecIBA 01/2020
1	Insulin Aspart (NovoLog)FDA Link 12/2019
1	AnticoagulantsIBA 07/2019
1	RivaroxabanIBA 07/2019
1	Alkylating AgentsIBA 01/2019
1	Autocrine Motility Factor ReceptorsIBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	veliparibIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	olaparibIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	4-(phenylthio)butanoic acidIBA 01/2016
1	aristolochic acid I (aristolochic acid)IBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	EstersIBA 01/2016
1	AlkaloidsIBA 01/2015
1	Vincristine (Oncovin)FDA LinkGeneric 01/2015
1	Taxoids (Taxanes)IBA 01/2015
1	N- (1'- naphthyl)- 3,4,5- trimethoxybenzohydrazideIBA 01/2015
1	Leucine (L-Leucine)FDA Link 06/2014
1	Chalcone (Benzalacetophenone)IBA 05/2013
1	ChalconesIBA 05/2013
1	LigandsIBA 05/2013
1	Colchicine FDA LinkGeneric 05/2013
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2013
1	Urokinase Plasminogen Activator ReceptorsIBA 04/2013
1	Cadherins (E-Cadherin)IBA 04/2013
1	benzyl isothiocyanateIBA 04/2013
1	VimentinIBA 04/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2012
1	ThiosemicarbazonesIBA 06/2012
1	hydrazinecarbothioamideIBA 06/2012
1	4-nitrophenylIBA 06/2012
1	2-acetylpyridine thiosemicarbazoneIBA 06/2012
1	2-acetylpyridineIBA 06/2012
1	Bortezomib (Velcade)FDA Link 05/2012

Therapy/Procedure

7	Therapeutics 01/2023 - 02/2008
2	Bariatric Surgery 01/2023 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2015
1	General Anesthesia 01/2023
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023
1	Anesthesia 01/2023
1	Liver Transplantation 07/2019
1	One-Lung Ventilation 08/2016
1	Treatment Delay 01/2016
1	Chemoprevention 04/2013